Details:

Alternative Title:
Vaccine
Publisher's site:
http://dx.doi.org/10.1016/j.vaccine.2015.06.073
Personal Author:
Chen, Robert T. ; Shimabukuro, Tom T. ; Martin, David B. ; Zuber, Patrick L.F. ; Weibel, Daniel M. ; ... More +
Chen, Robert T. ; Shimabukuro, Tom T. ; Martin, David B. ; Zuber, Patrick L.F. ; Weibel, Daniel M. ; Sturkenboom, Miriam ; Less -
Description:
Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.
Subject:
[+]
Adverse Drug Reaction Reporting Systems
AEFI
Article
Capacity Building
Drug Approval
Europe
Humans
Immunization Programs
Licensure
LMICs
Product Surveillance, Postmarketing
Safety
Sustainability
Vaccination
Vaccines
Vaccine Safety

Source:
Vaccine. 33(0 4):D46-D54
Pubmed ID:
26433922
Pubmed Central ID:
PMC4663114
Document Type:
Journal Article ;
Funding:
001/World Health Organization/International ; CC999999/Intramural CDC HHS/United States ;
001/World Health Organization/International ; CC999999/Intramural CDC HHS/United States ; Less -
Place as Subject:
United States ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:a7d312ebf1916d5bc78a671015c246907e3216a6ca623862348c799f99b3d247
File Type:

Supporting Files

• 	nihms732969.nxml	xml
  	nihms732969f1.gif	gif
  	nihms732969f1.jpg	jpeg

More +